Israel China Biotechnology (ICB) Ltd (ICB) — Long-term Investment Intensity
Israel China Biotechnology (ICB) Ltd (ICB) has a Long-term Investment Intensity of 44.9% as of June 2019. Long-term investments of ILA6.17 Million represent 44.9% of total assets of ILA13.74 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how high is Israel China Biotechnology (ICB) Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Israel China Biotechnology (ICB) Ltd Long-term Investment Intensity (2018–2018)
This chart shows how Israel China Biotechnology (ICB) Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of June 2019, the intensity stands at 44.9%, reflecting long-term investments of ILA6.17 Million against total assets of ILA13.74 Million ILA. Explore Israel China Biotechnology (ICB) Ltd (ICB) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Israel China Biotechnology (ICB) Ltd (2018–2018)
The table below presents the year-by-year Long-term Investment Intensity for Israel China Biotechnology (ICB) Ltd from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Israel China Biotechnology (ICB) Ltd market capitalisation.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 34.3% | ILA3.39 Million | ILA9.88 Million | — |